Security key
03837C106
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 18,770,221
- Total 13F value
- $94,412,555
- Share change
- -1,313,969
- Put/Call ratio
- 1.6%
- SEC-reported price per share
- $5.03
- Number of holders
- 55
- Value change
- -$2,505,631
- Number of buys
- 25
- Number of sells
- 29
- Shares outstanding
- 41,921,434
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
55
Top holders
10
APYX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Apyx Medical Corp SEC filings
Apyx Medical Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03837C106
Recent filing periods:
Ownership snapshot
Top reported holders of APYX - Apyx Medical Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Archon Capital Management...
Disclosed value leader
Archon Capital Management...
Comparable rows
15/15
Latest evidence
31 Mar 2023
13F
Lead comparable stake: 8.2%
Showing 1-6 of 15 holder rows.
Quick read
Archon Capital Management LLC leads the comparable SEC ownership view at 8.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Archon Capital Management LLC's linked filing trail.
Comparable ownership
Top 5
Archon Capital Management LLC
8.2%
RTW INVESTMENTS, LP
8.1%
COWEN AND COMPANY, LLC
4.2%
VANGUARD GROUP INC
3.5%
PURA VIDA INVESTMENTS, LLC
3.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Archon Capital Management LLC |
13F
Company
|
8.2%
|
$9,941,846
3,452,030 shares
|
— | 31 Mar 2023 |
| RTW INVESTMENTS, LP |
13F
Company
|
8.1%
|
$9,787,044
3,398,279 shares
|
— | 31 Mar 2023 |
| COWEN AND COMPANY, LLC |
13F
Company
|
4.2%
|
$5,114,283
1,775,793 shares
|
— | 31 Mar 2023 |
| VANGUARD GROUP INC |
13F
Company
|
3.5%
|
$4,278,036
1,485,429 shares
|
— | 31 Mar 2023 |
| PURA VIDA INVESTMENTS, LLC |
13F
Company
|
3.5%
|
$4,237,223
1,471,258 shares
|
— | 31 Mar 2023 |
| ROYCE & ASSOCIATES LP |
13F
Company
|
3.5%
|
$4,196,785
1,457,217 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
55
Shares
18,770,221
Rows available
55
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
54
Q2 2023 holders
55
Holder diff
1
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend